GSA Capital Partners’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-31,055
Closed -$128K – 2080
2026
Q2
$128K Buy
+31,055
New +$137K 0.01% 1604
2025
Q2
– Sell
-103,803
Closed -$565K – 1964
2025
Q1
$565K Buy
103,803
+29,582
+40% +$168K 0.05% 711
2024
Q4
$367K Buy
+74,221
New +$389K 0.03% 1096
2024
Q2
– Sell
-21,902
Closed -$225K – 1865
2024
Q1
$225K Buy
+21,902
New +$162K 0.02% 1356
2022
Q2
– Sell
-146,955
Closed -$519K – 1618
2022
Q1
$519K Buy
+146,955
New +$522K 0.07% 502

Other funds holding LFMD

GSA Capital Partners's LFMD Position: Q3 2026 in Review

GSA Capital Partners sold out of LifeMD (LFMD) in Q3 2026, closing a stake of 31,055 shares — an estimated $128K sold.

GSA Capital Partners first reported a position in LFMD in Q1 2022 and held it in 5 quarters. The position peaked at $565K in Q1 2025. 93 funds tracked by Wall St. Rank hold LFMD as of Q3 2026.

  • GSA Capital Partners reported no remaining LifeMD position as of Q3 2026 after selling out during the quarter.
  • GSA Capital Partners sold 31,055 LifeMD shares in Q3 2026, an estimated $128K.
  • GSA Capital Partners first reported a position in LifeMD in Q1 2022 and held it in 5 quarters.
  • GSA Capital Partners's LifeMD position peaked at $565K in Q1 2025.
  • 93 funds tracked by Wall St. Rank held LifeMD as of Q3 2026.

Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.